samedan logo

 
 
spacer
home > contact us
CONTACT US


   

Address

Samedan Ltd

Suite E, 11 Bell Yard Mews

175 Bermondsey Street

London

SE1 3TN




Email

info@samedanltd.com




Telephone Number

+44 (0)20 7724 3456




Fax Number

+44 (0)20 7403 7747




Subscriptions and Data Management

Beeline Data Services Ltd

Tel: 01342 312593

Fax: 01342 770131

Email: samedan@beelinedata.co.uk

www.beelinedata.co.uk





Rights / Permissions

Welcome to Samedan’s permissions enquiry page.

For all permissions requests to reuse content from Samedan Ltd are now being processed through PLSclear.

Search for the article you wish to use by title, author name, article title, author name, Article No or Company; complete
the following form with as much information as possible;
and submit. We will respond as quickly as possible (info@samedanltd.com)




spacer

Industry Events

DIA Europe 2021

15-19 March 2021, VIRTUAL CONFERENCE

DIA Europe is the must-attend event for all life science professionals working in drug development, from discovery to marketed use. It encourages open collaboration by bringing together representatives from the entire spectrum of the life science landscape and facilitating crucial discussions across several topic tracks: Clinical Development, Regulatory Strategy, Pharmacovigilance, Value and Access, Health Policy, and many more.
More info >>

News and Press Releases

Avacta announces license agreement with POINT Biopharma Inc.

Cambridge and Wetherby, UK, 07 January 2021: Avacta Group plc (AIM: AVCT), the developer of innovative cancer therapies and diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, is pleased to announce that it has entered into a license agreement with POINT Biopharma Inc. (“POINT”), to provide access to Avacta’s pre|CISION technology for the development of tumour-activated radiopharmaceuticals.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement